For these control points of immune differentiation, in several animal models of disease (e.g., RA, IBD, MS, and SLE), gene modulation has been found to regulate the expression of interleukins, TNF, CTLA-4, and IFNγ and mitigate the infiltration of lymphocytes into the affected organs [29]. The gene discussed is TNF; the disease is inflammatory bowel disease.